44 26 February 2026 false false false false false false false false false false true false false false false false false No description of principal activity 2024-09-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 03096460 2024-09-01 2025-08-31 03096460 2025-08-31 03096460 2024-08-31 03096460 2023-09-01 2024-08-31 03096460 2024-08-31 03096460 2023-08-31 03096460 core:NetGoodwill 2024-09-01 2025-08-31 03096460 core:PlantMachinery 2024-09-01 2025-08-31 03096460 core:FurnitureFittings 2024-09-01 2025-08-31 03096460 bus:Director1 2024-09-01 2025-08-31 03096460 core:NetGoodwill 2025-08-31 03096460 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-08-31 03096460 core:PlantMachinery 2024-08-31 03096460 core:FurnitureFittings 2024-08-31 03096460 core:PlantMachinery 2025-08-31 03096460 core:FurnitureFittings 2025-08-31 03096460 core:WithinOneYear 2025-08-31 03096460 core:WithinOneYear 2024-08-31 03096460 core:ShareCapital 2025-08-31 03096460 core:ShareCapital 2024-08-31 03096460 core:RetainedEarningsAccumulatedLosses 2025-08-31 03096460 core:RetainedEarningsAccumulatedLosses 2024-08-31 03096460 core:BetweenOneFiveYears 2025-08-31 03096460 core:BetweenOneFiveYears 2024-08-31 03096460 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-08-31 03096460 core:PlantMachinery 2024-08-31 03096460 core:FurnitureFittings 2024-08-31 03096460 bus:SmallEntities 2024-09-01 2025-08-31 03096460 bus:Audited 2024-09-01 2025-08-31 03096460 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 03096460 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 03096460 bus:FullAccounts 2024-09-01 2025-08-31
COMPANY REGISTRATION NUMBER: 03096460

PROACT MEDICAL LIMITED

FILLETED FINANCIAL STATEMENTS

31 August 2025

PROACT MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION

31 August 2025

| 2025 | 2024
Note | £ | £ | £ | £

FIXED ASSETS

Intangible assets | 5 |  | 6,458 |  | 6,458
Tangible assets | 6 |  | 39,533 |  | 44,271
|  | -------- |  | --------
|  | 45,991 |  | 50,729

CURRENT ASSETS

Stocks | 3,255,797 |  | 2,859,704 |
Debtors | 7 | 3,921,348 |  | 3,713,352 |
Cash at bank and in hand | 2,330,020 |  | 2,755,412 |
| ------------ |  | ------------ |
| 9,507,165 |  | 9,328,468 |

CREDITORS: amounts falling due within one year | 8 | 945,134 |  | 735,014 |
| ------------ |  | ------------ |
NET CURRENT ASSETS |  | 8,562,031 |  | 8,593,454
|  | ------------ |  | ------------
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 8,608,022 |  | 8,644,183

PROVISIONS |  | 9,884 |  | 11,068
|  | ------------ |  | ------------
NET ASSETS |  | 8,598,138 |  | 8,633,115
|  | ------------ |  | ------------

CAPITAL AND RESERVES

Called up share capital fully paid |  | 100 |  | 100
Profit and loss account |  | 8,598,038 |  | 8,633,015
|  | ------------ |  | ------------
SHAREHOLDERS FUNDS |  | 8,598,138 |  | 8,633,115
|  | ------------ |  | ------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

PROACT MEDICAL LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

31 August 2025
These financial statements were approved by the board of directors and authorised for issue on 26 February 2026 , and are signed on behalf of the board by:

Mr N Manners
Director

Company registration number: 03096460

PROACT MEDICAL LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 31 AUGUST 2025
1. GENERAL INFORMATION
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 9-13 Oakley Hay Lodge, Great Folds Road, Corby, Northamptonshire, NN18 9AS.
2. STATEMENT OF COMPLIANCE
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. ACCOUNTING POLICIES
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Operating leases
Lease payments are recognised as an expense over the lease term on a straight-line basis. The aggregate benefit of lease incentives is recognised as a reduction to expense over the lease term, on a straight-line basis.
Goodwill
Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

| Goodwill | - | 10% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Research and development
Research expenditure is written off in the period in which it is incurred. Development expenditure incurred is capitalised as an intangible asset only when all of the following criteria are met: - It is technically feasible to complete the intangible asset so that it will be available for use or sale; - There is the intention to complete the intangible asset and use or sell it; - There is the ability to use or sell the intangible asset; - The use or sale of the intangible asset will generate probable future economic benefits; - There are adequate technical, financial and other resources available to complete the development and to use or sell the intangible asset; and - The expenditure attributable to the intangible asset during its development can be measured reliably. Expenditure that does not meet the above criteria is expensed as incurred.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Computer Equipment | - | 25% reducing balance
| Fixtures, Fittings & Plant | - | 25% reducing balance

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit and loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit and loss.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. EMPLOYEE NUMBERS
The average number of persons employed by the company during the year amounted to 44 (2024: 44 ).
5. INTANGIBLE ASSETS

| Goodwill | Development costs | Total
| £ | £ | £
Cost |  |  |
At 1 September 2024 and 31 August 2025 | 40,000 | 6,458 | 46,458
| -------- | ------- | --------
Amortisation |  |  |
At 1 September 2024 and 31 August 2025 | 40,000 | – | 40,000
| -------- | ------- | --------
Carrying amount |  |  |
At 31 August 2025 | – | 6,458 | 6,458
| -------- | ------- | --------
At 31 August 2024 | – | 6,458 | 6,458
| -------- | ------- | --------

6. TANGIBLE ASSETS

| Plant and machinery | Fixtures and fittings | Total
| £ | £ | £
Cost |  |  |
At 1 September 2024 | 87,814 | 129,216 | 217,030
Additions | 141 | 7,400 | 7,541
| -------- | --------- | ---------
At 31 August 2025 | 87,955 | 136,616 | 224,571
| -------- | --------- | ---------
Depreciation |  |  |
At 1 September 2024 | 59,924 | 112,835 | 172,759
Charge for the year | 6,946 | 5,333 | 12,279
| -------- | --------- | ---------
At 31 August 2025 | 66,870 | 118,168 | 185,038
| -------- | --------- | ---------
Carrying amount |  |  |
At 31 August 2025 | 21,085 | 18,448 | 39,533
| -------- | --------- | ---------
At 31 August 2024 | 27,890 | 16,381 | 44,271
| -------- | --------- | ---------

7. DEBTORS

| 2025 | 2024
| £ | £
Trade debtors | 2,020,088 | 2,126,622
Other debtors | 1,901,260 | 1,586,730
| ------------ | ------------
| 3,921,348 | 3,713,352
| ------------ | ------------

8. CREDITORS: amounts falling due within one year

| 2025 | 2024
| £ | £
Trade creditors | 462,310 | 229,283
Social security and other taxes | 52,452 | 91,201
Other creditors | 430,372 | 414,530
| --------- | ---------
| 945,134 | 735,014
| --------- | ---------

9. OPERATING LEASES
The total future minimum lease payments under non-cancellable operating leases are as follows:

| 2025 | 2024
| £ | £
Not later than 1 year | 1,629 | 6,554
Later than 1 year and not later than 5 years | 124,788 | 228,721
| --------- | ---------
| 126,417 | 235,275
| --------- | ---------

The above commitment includes an average annual rental of £92,664 in respect of the lease of land and buildings, which is due to expire on 1 October 2026.
10. SUMMARY AUDIT OPINION
The auditor's report dated 26 February 2026 was unqualified .
The senior statutory auditor was David Kelland FCA , for and on behalf of Meadows & Co Limited .
11. RELATED PARTY TRANSACTIONS
During the year there were the following transactions with directors: The directors have advanced funds to the company. At the year end the amount owed by the company was £ 351,596 (2024 £ 343,142 ). Dividends paid to the directors totalled £944,960 (2024 £979,960). Remuneration paid to the directors totalled £277,752 (2024 £291,987). There are no Key Management Personnel other than the directors. The company has taken advantage of the provisions available under FRS 102 not to disclose transactions and balances with companies under common control.